previous compound ID: 2851 next compound
InChIKey: ZSKVGTPCRGIANV-ZXFLCMHBSA-N
SMILES: C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "J Liao" "E Matthes" "D Rotin" "JW Hanrahan" "B Kus" "DY Thomas" "GW Carlile" "R Robert" "SD Macknight"

chemical graph of compound 2851





CID is 104838
synonyms found at PubChem are:
imipenem, Imipemide, N-Formimidoylthienamycin, 64221-86-9, Imipenem anhydrous, Tienamycin, Imipenemum, N-formimidoyl thienamycin, Imipenen, MK 0787, Imipenem, N-Formimidoyl thienamycin, (5R,6S)-6-((R)-1-Hydroxyethyl)-3-(2-(iminomethylamino)ethylthio)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carbonsaeure, UNII-Q20IM7HE75, Imipenem (INN), Primaxin, CHEBI:471744, CHEMBL148, Q20IM7HE75, (5R,6S)-3-((2-(Formimidoylamino)ethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, Imipenem [INN], Imipenemum [Latin], (5R,6S)-3-(2-Formimidoylamino-ethylsulfanyl)-6-((R)-1-hydroxy-ethyl)-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid, DSSTox_CID_3143, DSSTox_RID_76888, DSSTox_GSID_23143, (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, EINECS 264-734-5, MK-787, (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}thio)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-, (5R,6S)-, CAS-64221-86-9, SR-05000000294, NCGC00016928-01, Primaxin (TN), (5R,6S)-3-[2-(aminomethyleneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-(2-methanimidamidoethylsulfanyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-((1R)-1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R,6S)-, Prestwick_844, AC1L2XLB, Prestwick0_000519, Prestwick1_000519, Prestwick2_000519, Prestwick3_000519, D0H3TD, Epitope ID:120384, BSPBio_000477, BIDD:GT0686, SPBio_002398, BPBio1_000525, SCHEMBL1649260, SCHEMBL8781920, DTXSID2023143, ZSKVGTPCRGIANV-ZXFLCMHBSA-N, HMS1569H19, HMS2090A15, HMS2096H19, HMS3260H20, HMS3713H19, Pharmakon1600-01506001, 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5-alpha,6-alpha(R*)))-, 64221-86-9 (Parent), BCP13012, ZINC4097225, Tox21_110689, Tox21_500279, BDBM50049708, NSC717864, NSC759901, AKOS016010844, Tox21_110689_1, AN-9651, CCG-220519, CCG-221583, DB01598, LP00279, NSC-717864, NSC-759901, 64221-86-9 (ANHYDROUS), NCGC00167958-01, NCGC00167958-02, NCGC00167958-03, NCGC00167958-05, NCGC00260964-01, AJ-47996, AN-15734, BC209124, FT-0627191, C06665, D04515, X-2302, AB01563339_01, 847I667, SR-05000000294-2, SR-05000000294-5, (5R,6S)-3-((2-formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (5R,6S)-3-({2-[(E)-(aminomethylidene)amino]ethyl}sulfanyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (5R,6S)-3-(2-formimidamidoethylthio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (5R,6S)-6-[(1R)-1-hydroxyethyl]-3-({2-[(iminomethyl)amino]ethyl}sulfanyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, [5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2- [(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylic acid monohydrate, [5R-[5.alpha.,6.alpha.(R*)]]-6-(1-Hydroxyethyl)-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monohydrate, 103730-39-8, 127644-14-8, 3-[(2-Aminoethyl)thio]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid (4-nitrophenyl)methylester monohydrochloride compd. with 1-methyl-2-pyrrolidinone (1:1), 345631-68-7, 75902-88-4